Literature DB >> 6309645

Pleomorphic adenoma, I: Ultrastructural organization of "epithelial" regions.

I Dardick, A W van Nostrand, M T Jeans, P Rippstein, V Edwards.   

Abstract

Twenty-four major and minor salivary gland pleomorphic adenomas were studied ultrastructurally to determine the growth patterns, organization, and cytologic modifications of the proliferating neoplastic cells. In compact and highly cellular regions, two cell types--luminal epithelial and myoepithelial--could often be identified; their organization mimicked that of the normal salivary gland duct or acinar unit. Results of the study indicate that the principal proliferating tumor cell is a structurally modified myoepithelial cell that frequently shows squamous differentiation. At the immediate margins of cellular regions of many tumor cells, gradual dedifferentiation of modified myoepithelial cells with a loss of squamous features occurs, although in some cells the squamous features are retained to varying degrees. Within cellular regions, the earliest development of matrix occurs in relation to small, basal lamina-lined extracellular spaces between myoepithelial-like cells. Modifications of such intercellular spaces are helpful in tracing the development of myxoid zones and the evolution of cell types in this unique region. The authors postulate that salivary gland pleomorphic adenomas result from the neoplastic transformation of the complete ductal-acinar unit rather than from one particular ductal "reserve" cell.

Entities:  

Mesh:

Year:  1983        PMID: 6309645     DOI: 10.1016/s0046-8177(83)80301-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  26 in total

1.  S-100 protein antibodies do not label normal salivary gland myoepithelium. Histogenetic implications for salivary gland tumors.

Authors:  I Dardick; M Stratis; W R Parks; F G DeNardi; H J Kahn
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

2.  Immunohistochemical distribution of human epidermal growth factor in salivary gland tumours.

Authors:  M Mori; R Naito; K Tsukitani; Y Okada; T Hayashi; K Kato
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Cytokeratin polypeptides expression in different epithelial elements of human salivary glands.

Authors:  S Geiger; B Geiger; O Leitner; G Marshak
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  Epimyoepithelial' islands in lymphoepithelial lesions. An immunocytochemical study.

Authors:  R M Palmer; J W Eveson; B A Gusterson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

5.  Mucosubstance histochemistry of pleomorphic adenoma of parotid and submandibular salivary glands of man: light and electron microscopy.

Authors:  J D Harrison; D W Auger
Journal:  Histochem J       Date:  1991-07

Review 6.  Functional Histology of Salivary Gland Pleomorphic Adenoma: An Appraisal.

Authors:  Asterios Triantafyllou; Lester D R Thompson; Kenneth O Devaney; Diana Bell; Jennifer L Hunt; Alessandra Rinaldo; Vincent Vander Poorten; Alfio Ferlito
Journal:  Head Neck Pathol       Date:  2014-11-08

7.  Distribution of intermediate filament proteins in developing and adult salivary glands in man.

Authors:  H Gustafsson; U Kjörell; A Eriksson; I Virtanen; L E Thornell
Journal:  Anat Embryol (Berl)       Date:  1988

8.  A note on the histochemical and morphological characterization of the asbestoid degeneration of cartilage.

Authors:  S R Line; H Torloni; G S Montes; L C Junqueira
Journal:  Histochemistry       Date:  1988

9.  Ultrastructural observations on luminal structures of pleomorphic adenoma of parotid and submandibular salivary glands of man.

Authors:  J D Harrison; D W Auger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

10.  Salivary gland monomorphic adenoma. Ultrastructural, immunoperoxidase, and histogenetic aspects.

Authors:  I Dardick; H J Kahn; A W Van Nostrand; R Baumal
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.